Dendrobium officinale polysaccharide with effect of improving oral mucositis as well as preparation method and application of dendrobium officinale polysaccharide

The treatment of Dendrobium officinale by solvent extraction and Sevage combined with enzyme method improves the purity and anti-inflammatory effect of polysaccharides, solves the treatment problems of chemotherapeutic oral mucositis, and achieves efficient and safe preparation and application of polysaccharides.

CN118930672APending Publication Date: 2024-11-12JINHUA SHOUXIANGU PHAMACEUTICAL CO LTD +2
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410981395.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art cannot effectively prevent and treat chemotherapeutic oral mucositis. Commonly used drugs have limited efficacy and drug resistance and side effects. The extraction process of Dendrobium officinale polysaccharide is complex and has low purity, making it difficult to produce on a large scale.

Method used

The solvent extraction method was used to remove fat-soluble ingredients and alcohol-soluble sugars, and protein was removed by Sevage combined with enzyme method, which increased the yield and purity of Dendrobium officinale polysaccharide, and the high molecular weight polysaccharides were retained by ultrafiltration to reduce the use of polysaccharides and preparation cost.

Benefits of technology

It significantly improved the purity and anti-inflammatory inhibitory effect of Dendrobium officinale polysaccharide, reduced the dosage of drugs, improved the application value, and verified its significant inhibitory effect and safety on oral mucositis through in vitro cell and in vivo animal experiments.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118930672A_ABST
    Figure CN118930672A_ABST
Patent Text Reader

Abstract

The invention provides dendrobium officinale polysaccharide with an effect of improving oral mucositis as well as a preparation method and application of the dendrobium officinale polysaccharide, and relates to the technical field of polysaccharide preparation. The preparation method comprises the following steps: mixing dendrobium officinale with a solution in a weight ratio of 1: (8-18), repeatedly extracting for 4-5 times, and combining filter residues; mixing filter residues with 15-35 times by volume of water, extracting for 1-4 hours, extracting for 2-3 times, and combining filtrates; concentrating at 40-50 DEG C to obtain a precipitate; removing the solvent, deproteinizing by a Sevage enzyme-linked method, and collecting an upper-layer polysaccharide aqueous solution; dialyzing the polysaccharide aqueous solution for 40-50 hours, and concentrating to obtain a crude product; dissolving the crude product, performing ultrafiltration separation, performing ultrafiltration for 5-10 times by using a 75-85kDa membrane, and collecting penetrating fluid. The invention further provides the prepared dendrobium officinale polysaccharide and application of the dendrobium officinale polysaccharide in preparation of products for preventing or improving or treating oral mucositis, the yield of the polysaccharide is increased, and the purity of the polysaccharide is guaranteed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of polysaccharide preparation, and in particular to a Dendrobium officinale polysaccharide having the effect of improving oral mucositis, and a preparation method and application thereof. Background Art

[0002] Oral mucositis is one of the more common oral diseases currently and belongs to the category of oral mucosal diseases. The prevalence of oral mucositis ranks first among oral mucosal diseases. Chemotherapy-induced oral mucositis is one of the common diseases caused by the killing of normal tissues by chemotherapy drugs. Chemotherapy-induced oral mucositis is characterized by periodicity, recurrence, and self-limitation. Because oral mucositis seriously affects the quality of life of patients in terms of oral hygiene, oral function, and nutritional intake, how to effectively prevent and effectively treat chemotherapy-induced oral mucositis as soon as possible is particularly important. However, there is currently no specific method for this disease, so research on the etiology and treatment methods of oral mucositis has become a hot topic.

[0003] Dendrobium officinale is an important medicinal resource widely distributed in southern my country. As a traditional Chinese medicine, Dendrobium officinale has the effects of nourishing the stomach and promoting fluid production, nourishing yin and clearing away heat. Modern pharmacological studies have shown that Dendrobium officinale has anti-inflammatory, anti-tumor, antioxidant and antiviral effects, but there are few reports on the improvement of oral mucositis by Dendrobium officinale. Therefore, exploring the effect of Dendrobium officinale on improving oral mucositis is an effective way to improve the application value of Dendrobium officinale. Among the dozens of chemical substances that have been identified in Dendrobium plants, polysaccharides are the main components of their health benefits. Previous studies have shown that Dendrobium officinale polysaccharides have pharmacological activities such as antiviral, anti-aging and neuroprotective effects, as well as immunomodulatory effects, and their main uses include the treatment of inflammation, cancer and immune system diseases.

[0004] At present, drug therapy is the main method for treating oral mucositis and other digestive tract inflammations, including analgesics, anesthetics, anti-inflammatory agents, etc., which can relieve disease symptoms for local treatment. However, commonly used drugs such as corticosteroids, mesalamine and doxycycline not only have limited efficacy, but also may lead to increased drug resistance after long-term use, and easily cause patients to have side effects such as liver toxicity and reduced immunity, which has some limitations. Therefore, based on existing research, it is necessary to develop new food-borne functional factors that are safer and more effective in alleviating the occurrence and development of digestive tract inflammation.

[0005] Patent CN 114605565 A discloses a polysaccharide from Dendrobium candidum and its preparation method and application. The preparation method comprises mixing a small segment of fresh Dendrobium candidum with distilled water, breaking the wall and homogenizing to obtain a slurry and a concentrated solution, dissolving the alcohol precipitate in water after alcohol precipitation, passing it through an ultrafiltration membrane, collecting the trapped liquid and freeze-drying it to obtain a polysaccharide freeze-dried powder. The process is simple to operate, but the content of the polysaccharide obtained is low. If a better improvement effect is to be achieved later, repeated preparation is required, and the application cost is high. Patent CN 111196865B discloses a method for extracting the active ingredients of Dendrobium candidum. The invention performs ethyl acetate degreasing and enzymolysis before conventional water extraction, and enzymolysis before deproteinization with Sevage reagent, which effectively ensures a high extraction rate and high activity of Dendrobium candidum polysaccharide. However, the preparation process is complicated, and the proposed polysaccharide has a low purity and a large amount of impurities, which is not conducive to mass production. Patent CN 110859288 A discloses a method for preparing Dendrobium officinale and betel nut with the effect of improving oral microecology. The invention utilizes the antibacterial, anti-inflammatory and antiviral effects of Dendrobium officinale to reduce oral damage, but the barrier repair function for oral mucositis cannot be determined, and the effective ingredients are complex and the mechanism of action cannot be proved. Patent CN 110452312 A discloses a Huoshan Dendrobium polysaccharide with anti-digestive system cancer effect. The invention prepares Huoshan Dendrobium polysaccharide with anti-digestive system cancer effect through pectinase and high-temperature resistant amylase hydrolysis process combined with anion and cation exchange resin purification process. However, the invention is effective for digestive system diseases and lacks targeting for oral mucositis in digestive system diseases.

[0006] Based on this, the present invention provides a method for preparing a Dendrobium officinale polysaccharide with the effect of improving oral mucositis and its application in the preparation of a product for preventing, improving or treating oral mucositis. The prepared Dendrobium officinale polysaccharide has a good improvement effect on oral mucositis caused by chemotherapy, and has no toxic side effects, thereby achieving the effect of relieving oral mucositis safely and efficiently. Summary of the invention

[0007] In view of the above problems, the present invention provides a method for preparing a polysaccharide from Dendrobium officinale that has the effect of improving oral mucositis. The fat-soluble components and alcohol-soluble sugars are removed by solvent extraction, and proteins are removed by Sevage combined with an enzyme method, thereby increasing the yield of polysaccharides and ensuring the purity of polysaccharides.

[0008] To achieve the above purpose, the technical solution adopted by the present invention is as follows:

[0009] On the one hand, the present invention provides a method for preparing a Dendrobium officinale polysaccharide having the effect of improving oral mucositis, comprising the following steps:

[0010] S1: Mix Dendrobium officinale with the solution at a weight ratio of 1:8-18, collect the residue after 6-12 hours; repeat the extraction 4-5 times, and combine the residue;

[0011] S2: Mix the filter residue obtained in S1 with 15-35 times the volume of water, extract at 65-90°C for 1-4h, extract 2-3 times, and combine the filtrates;

[0012] S3: The filtrate obtained in S2 is concentrated at 40-50°C and precipitated with alcohol to obtain a precipitate;

[0013] S4: removing the solvent from the precipitate obtained in S3 to obtain crude polysaccharide of Dendrobium officinale;

[0014] S5: Deproteinize by Sevage enzyme-linked method and collect the upper polysaccharide aqueous solution.

[0015] Preferably, the Dendrobium officinale described in S1 is dried, crushed, and sieved;

[0016] Preferably, the mesh number of the sieve is 50-120 mesh; further preferably, the mesh number of the sieve is 60-100 mesh; more preferably, the mesh number of the sieve is 80 mesh.

[0017] Preferably, the solution described in S1 is an ethanol-water solution, and the volume fraction of ethanol is 70%-90%; more preferably, the volume fraction of ethanol is 85%.

[0018] Preferably, the weight ratio described in S1 is 1:10-15; further preferably, the weight ratio described in S1 is 1:10.

[0019] Preferably, the mixing described in S1 can be stirring, and the stirring time is 6-12 hours, and more preferably, the stirring time is 8-10 hours.

[0020] Preferably, S2 comprises mixing the filter residue obtained in S1 with 20-30 times the volume of water; further preferably, S2 comprises mixing the filter residue obtained in S1 with 20 times the volume of water.

[0021] Preferably, the water described in S2 is selected from at least one of deionized water, distilled water and purified water; further preferably, the water described in S2 is selected from deionized water.

[0022] Preferably, the extraction temperature in S2 is 70-85°C, and the extraction time is 2-3h; further preferably, the extraction temperature in S2 is 70°C, and the extraction time is 2h.

[0023] Preferably, S2 further comprises the step of: centrifuging the obtained filtrate; the centrifugation parameters are: centrifugation at a speed of 7500-8500 rpm / min for 10-25 min; further preferably, the centrifugation parameters of S2 are: centrifugation at a speed of 8000 rpm / min for 15-20 min.

[0024] Preferably, the solvent for the alcohol precipitation in S3 is an ethanol aqueous solution, and the volume fraction of ethanol is 90%-95%; further preferably, the volume fraction of ethanol is 95%.

[0025] Preferably, the final concentration of ethanol in the filtrate described in S3 is 75%-80%, and more preferably, the final concentration of ethanol in the filtrate described in S3 is 80%.

[0026] Preferably, the concentration temperature in S3 is 45°C.

[0027] Preferably, the alcohol precipitation in S3 further comprises standing and centrifuging;

[0028] Preferably, the standing temperature is 3-5°C and the time is 10-16h; more preferably, the standing temperature is 4°C and the time is 12h.

[0029] Preferably, the method of removing the solvent in S4 is: dissolving in water and rotary evaporation.

[0030] Preferably, the solvent described in S4 is ethanol.

[0031] Preferably, the specific operation of the Sevage enzyme-linked deproteinization method described in S5 is: taking crude polysaccharide of Dendrobium officinale and adding a solvent to prepare a solution with a mass fraction of 3-5%, adding trypsin, and treating at a constant temperature of 45-55°C, taking the supernatant and mixing it with the Sevage reagent, so that the final concentration of the Sevage reagent is 18-22%; the Sevage reagent is a mixed solution of chloroform and n-butanol;

[0032] Preferably, the solvent described in S5 is distilled water.

[0033] Preferably, the amount of trypsin added in S5 is 135-145 U / mL; further preferably, the amount of trypsin added in S5 is 140 U / mL.

[0034] Preferably, the temperature in S5 is 45-50°C; further preferably, the temperature in S5 is 50°C.

[0035] Preferably, the final concentration of the Sevage reagent described in S5 is 18-20%; further preferably, the final concentration of the Sevage reagent described in S5 is 20%.

[0036] Preferably, the volume ratio of chloroform to n-butanol in S5 is 3-4:1; further preferably, the volume ratio of chloroform to n-butanol in S5 is 4:1.

[0037] Preferably, the preparation method further comprises the step of dialyzing the polysaccharide aqueous solution obtained in S5 for 40-50 hours, with a molecular cutoff of 3300-3600 kDa, and concentrating to obtain a crude product.

[0038] Preferably, the molecular cutoff is 3400-3500 kDa; further preferably, the molecular cutoff is 3500 kDa.

[0039] Preferably, the dialysis time is 45-48 hours, and more preferably, the dialysis time is 48 hours.

[0040] Preferably, the preparation method further comprises the steps of:

[0041] The crude product is dissolved and separated by ultrafiltration, and ultrafiltration is performed 5-10 times using a 75-85 kDa membrane, and the permeate is collected;

[0042] Preferably, the concentration of the crude product in the dissolved solution is 480 mg / L-500 mg / L, and further preferably, the concentration of the crude product in the dissolved solution is 500 mg / L.

[0043] Preferably, the ultrafiltration separation is: under the conditions of a pressure of 0.15-0.25 MPa and a flow rate of 25-35 L / h, using a 75-85 kDa membrane to continuously ultrafilter 5-10 times until the maximum permeate yield is reached, and the permeate is collected.

[0044] Further preferably, the ultrafiltration separation is: under the conditions of a pressure of 0.15-0.20 MPa and a flow rate of 25-30 L / h, using a 75-80 kDa membrane to continuously ultrafilter 5-10 times until the maximum permeate yield is reached, and the permeate is collected for freeze-drying.

[0045] More preferably, the ultrafiltration separation is: under the conditions of a pressure of 0.20 MPa and a flow rate of 30 L / h, using an 80 kDa membrane to continuously ultrafilter 5-10 times until the maximum permeate yield is reached, and the permeate is collected for freeze-drying.

[0046] On the other hand, the present invention provides a Dendrobium officinale polysaccharide having the effect of improving oral mucositis, which is prepared by the above preparation method.

[0047] In another aspect, the present invention provides a use of the Dendrobium officinale polysaccharide prepared by the above preparation method in preparing a product for preventing, improving or treating oral mucositis.

[0048] Preferably, the product is a health product or a medicine.

[0049] Compared with the prior art, the present invention has the following beneficial effects:

[0050] (1) The present invention uses Dendrobium officinale as raw material, removes fat-soluble components and alcohol-soluble sugars by solvent extraction, and uses Sevage combined with an enzyme method to remove proteins, thereby increasing the yield of polysaccharides and ensuring the purity of polysaccharides.

[0051] Specifically, the crude polysaccharide solution contains a large amount of protein, which will bind to the polysaccharide to form glycoproteins, which will have a great impact on the subsequent polysaccharide separation. By combining Sevage with an enzyme method to decompose plant tissues under milder conditions, the method is greener and more efficient, increases the protein removal rate, and reduces the amount of organic solvent used. The polysaccharide extraction rate reaches 26%, and the purity reaches 85%. Reducing the waste of precious medicinal resources can also obtain higher economic benefits. The present invention separates and retains high-molecular polysaccharides with a molecular weight of more than 80kDa through ultrafiltration, maintains the high activity of polysaccharides to a large extent, and reduces the amount of polysaccharides used.

[0052] (2) The high molecular weight polysaccharide prepared by the present invention is verified by in vitro cell experiments, and the high molecular weight polysaccharide has a strong inhibitory effect on inflammation at the same concentration. The present invention significantly improves the inhibitory effect of Dendrobium officinale polysaccharide on inflammation and reduces the amount of polysaccharide used.

[0053] Specifically, the traditional application method of Dendrobium officinale polysaccharide is to use the polysaccharide directly. However, this application method often requires a very high concentration of polysaccharide to achieve a good anti-inflammatory effect. In the case where the extraction cost of Dendrobium officinale polysaccharide is much higher than that of chemically synthesized anti-inflammatory drugs, the large-scale application and manufacturing cost is relatively high. The present invention has found through examples that, at the same concentration, the inflammatory factor inhibition rate of the high-molecular polysaccharide is 6%-21% higher than that of the unseparated polysaccharide; and at the same inflammatory factor inhibition rate, the high-molecular polysaccharide concentration is 16%-34% lower than that of the unseparated polysaccharide, which greatly improves the application value.

[0054] (3) The present invention provides a Dendrobium officinale polysaccharide that can protect the oral mucosal barrier, reduce oral inflammatory response, and improve pathological changes in oral epithelial tissue through in vitro cell and in vivo animal experiments. It is also effective against oral mucositis caused by chemotherapy and can significantly inhibit the occurrence and growth of oral mucositis without any toxic side effects.

[0055] Specifically, the dendrobium parts are extracted and concentrated by alcohol, some impurities are removed, and the high molecular weight polysaccharide parts are enriched with high purity, which effectively reduces the amount of medicine taken while maintaining the efficacy, and helps to improve the compliance of users. In addition, the polysaccharide of Dendrobium officinale has good immunomodulatory function, and when used in combination with drugs, it has the effects of reducing inflammatory response, improving human immunity, and reducing pathological changes in oral tissues, and has a good preventive and therapeutic effect on oral mucositis.

[0056] (4) In summary, the present invention provides a high molecular weight Dendrobium officinale polysaccharide with high anti-inflammatory activity, which has the effects of reducing cellular oxidative stress and inhibiting endoplasmic reticulum stress and inflammatory response, can reduce cell damage induced by chemotherapy drugs, has the effects of alleviating the symptoms of oral mucositis and improving related biochemical indicators in the oral cavity, and can be used to prepare drugs and health products for improving oral mucositis. BRIEF DESCRIPTION OF THE DRAWINGS

[0057] Figure 1 A technical route for preparing traditional Dendrobium officinale polysaccharides;

[0058] Figure 2 The technical route for preparing Dendrobium officinale polysaccharide of the present invention;

[0059] Figure 3 This is a graph showing the effect of Dendrobium officinale polysaccharide on HaCaT cell viability;

[0060] Figure 4 The oxidative stress level of HaCaT cells induced by 5-FU treated with Dendrobium officinale polysaccharide;

[0061] Figure 5 The levels of inflammatory factors in HaCaT cells induced by 5-FU treated with Dendrobium officinale polysaccharide;

[0062] Figure 6 The levels of Nrf2 signaling pathway and ERS in HaCaT cells induced by 5-FU were treated with Dendrobium officinale polysaccharide;

[0063] Figure 7 This is the tissue damage and cell apoptosis of rats after being treated with Dendrobium officinale polysaccharide;

[0064] Figure 8 is the level of inflammatory factors in rats treated with Dendrobium officinale polysaccharide;

[0065] Fig. 9 is the oxidative stress level of rats after being treated with Dendrobium officinale polysaccharide;

[0066] Fig.10 The NF-κB signaling pathway level and ERS level of rats treated with Dendrobium officinale polysaccharide;

[0067] Fig.11The levels of inflammatory factors and oxidative stress in rats after treatment with Dendrobium officinale polysaccharide microneedle patch. DETAILED DESCRIPTION

[0068] In order to make the technical means, creative features, purpose and effect of the present invention easy to understand, the present invention is further explained below in conjunction with specific embodiments, but the following embodiments are only preferred embodiments of the present invention, not all. Based on the embodiments in the implementation mode, other embodiments obtained by those skilled in the art without making creative work all belong to the protection scope of the present invention. It is worth noting that the raw materials used in the present invention are all common commercial products, and their sources are not specifically limited. The technology and scientific terms used in the embodiments have the meanings commonly understood by those of ordinary skill in the art to which the present invention belongs.

[0069] The raw materials used in the examples are:

[0070] Human immortalized keratinocytes HaCaT, Shenyang Wanlei Technology Co., Ltd., N11604335;

[0071] SD rats, Shenyang Wanlei Technology Co., Ltd.;

[0072] 5-Fluorouracil 5-Fu, 99%, Shenyang Wanlei Technology Co., Ltd., N11702672;

[0073] Nrf2 antibody (WB, IF, anti-human, anti-rat), Shenyang Wanlei Technology Co., Ltd., N02132135;

[0074] Keap1 antibody (WB, anti-human), Shenyang Wanlei Technology Co., Ltd., N02103285;

[0075] CHOP (DDIT3) antibody (WB, IHC, anti-human, anti-rat), Shenyang Wanlei Technology Co., Ltd., N11010880;

[0076] HO-1 antibody (WB, anti-human, anti-rat), Shenyang Wanlei Technology Co., Ltd., N12032400;

[0077] NQO1 antibody (WB, anti-human, anti-rat), Shenyang Wanlei Technology Co., Ltd., N03214860;

[0078] NF-κB p65 antibody (WB, IHC, anti-rat), Shenyang Wanlei Technology Co., Ltd., N11171980;

[0079] p-NF-κB p65 (Ser 536) antibody (WB, anti-rat), Shenyang Wanlei Technology Co., Ltd., N01222169;

[0080] GRP78 BiP antibody (WB, IHC, anti-rat), Shenyang Wanlei Technology Co., Ltd., N0163157;

[0081] mL385, 99%, Shenyang Wanlei Technology Co., Ltd., N12702575;

[0082] Sodium 4-phenylbutyrate 4-PBA, 99%, Shenyang Wanlei Technology Co., Ltd., N12502597;

[0083] Pyrrolidine dithiocarboxylic acid ammonium salt PDTC, 99%, Shenyang Wanlei Technology Co., Ltd., N12402485;

[0084] MTT cell proliferation and cytotoxicity detection kit, Shenyang Wanlei Technology Co., Ltd., 27A007;

[0085] Reactive oxygen species (ROS) detection kit, Shenyang Wanlei Technology Co., Ltd., 21A016;

[0086] Total superoxide dismutase (SOD) assay kit (WST-1 method), Shenyang Wanlei Technology Co., Ltd., 19A006;

[0087] Malondialdehyde (MDA) assay kit (TBA method), Shenyang Wanlei Technology Co., Ltd., 17A012;

[0088] Glutathione peroxidase (GSH-PX) assay kit (colorimetric method), Shenyang Wanlei Technology Co., Ltd., 16A015;

[0089] Catalase (CAT) assay kit (visible light method), Shenyang Wanlei Technology Co., Ltd., 24A009;

[0090] Human TNF-α ELISA detection kit, Shenyang Wanlei Technology Co., Ltd., 20A017;

[0091] Human IL-1β ELISA detection kit, Shenyang Wanlei Technology Co., Ltd., 15A049;

[0092] Human IL-6 ELISA detection kit, Shenyang Wanlei Technology Co., Ltd., 15A045;

[0093] Human IL-10 ELISA detection kit, Shenyang Wanlei Technology Co., Ltd., 15A046;

[0094] Rat TNF-α ELISA detection kit, Shenyang Wanlei Technology Co., Ltd., 20A014;

[0095] Rat IL-1β ELISA detection kit, Shenyang Wanlei Technology Co., Ltd., 15A019;

[0096] Rat IL-6 ELISA detection kit, Shenyang Wanlei Technology Co., Ltd., 15A023;

[0097] Rat IL-10 ELISA detection kit, Shenyang Wanlei Technology Co., Ltd., 15A027;

[0098] Whole protein extraction kit, Shenyang Wanlei Technology Co., Ltd., 12A122;

[0099] One-step TUNEL apoptosis detection kit (chromogenic method), Shenyang Wanlei Technology Co., Ltd., 20A080;

[0100] Masson trichrome stain, Shenyang Wanlei Technology Co., Ltd., 25A082.

[0101] Example 1

[0102] A Dendrobium officinale polysaccharide is prepared by the following method:

[0103] (1) Dry the fresh Dendrobium officinale, crush it with a grinder and pass it through an 80-mesh sieve.

[0104] (2) The Dendrobium officinale prepared in step (1) is mixed with 85% ethanol by volume, the weight ratio of the Dendrobium officinale to the ethanol being 1:10, and the mixture is magnetically stirred for 8 hours and then filtered to collect the residue. The process is repeated 3-4 times, and the residue is dried.

[0105] (3) Add 20 times the volume of distilled water to the decolorized Dendrobium officinale powder, extract at 70°C for 2 h, repeat twice, combine the filtrates and centrifuge at 8000 rpm / min for 15 min.

[0106] (4) The filtrate was rotary evaporated at 45°C. When the volume was concentrated to 1 / 5, 95% ethanol was added for alcohol precipitation so that the final ethanol concentration in the solution was 80%. The solution was allowed to stand at 4°C overnight and centrifuged to obtain a precipitate.

[0107] (5) The precipitate was re-dissolved in distilled water, the residual ethanol was removed by rotary evaporation, and then freeze-dried at -80°C for 48 h to obtain crude polysaccharide of Dendrobium officinale.

[0108] (6) Deproteinization was performed by Sevage enzyme-linked method. A 4% aqueous solution of crude polysaccharide from Dendrobium officinale leaves was added with trypsin at an addition amount of 140 U / mL, and the mixture was kept at a constant temperature of 50°C and centrifuged. The supernatant was mixed with Sevage reagent (chloroform: n-butanol = 4:1) to make the final concentration of Sevage reagent 20%.

[0109] (7) Place the solution in a separatory funnel, shake it repeatedly, let it stand, and collect the upper polysaccharide aqueous solution. Repeat the above steps 5-10 times until the lower organic phase is completely clear and transparent.

[0110] (8) After deproteinization, the polysaccharide solution was dialyzed in distilled water for 48 h using a dialysis bag with a molecular cutoff of 3500 kDa.

[0111] (9) After concentration, freeze-drying is performed to obtain crude polysaccharide of Dendrobium officinale.

[0112] (10) Take 500 mg of crude polysaccharide, dissolve it in 1 L of distilled water, and separate it by ultrafiltration. Under the conditions of pressure of 0.2 MPa and flow rate of 30 L / h, use 80 kDa membrane to continuously ultrafilter 5 times until the maximum permeate yield is reached. The permeate is collected and freeze-dried as described above to obtain high-molecular-weight Dendrobium officinale polysaccharide.

[0113] Extraction yield (%) = mass of extracted substance / total mass of raw materials * 100%

[0114] Total sugar content (%) = polysaccharide mass / extracted material mass * 100%

[0115] The polysaccharide extraction rate reached 31% and the total sugar content reached 85%.

[0116] Comparative Example 1

[0117] Compared with Example 1, only the weight ratio of Dendrobium officinale to ethanol in step 2 is changed to 1:5, and the remaining operations are the same as Example 1.

[0118] The polysaccharide extraction rate reached 23% and the purity reached 78%.

[0119] Comparative Example 2

[0120] Compared with Example 1, only the volume fraction of the ethanol solution in step 2 is changed to 65%, and the remaining operations are the same as those in Example 1.

[0121] The polysaccharide extraction rate reached 21% and the purity reached 75%.

[0122] Comparative Example 3

[0123] Compared with Example 1, only the addition of 38 times the volume of distilled water in step 3 and extraction at 55° C. for 5 h were changed. The remaining operations were the same as in Example 1.

[0124] The polysaccharide extraction rate reached 18% and the purity reached 78%.

[0125] Comparative Example 4

[0126] Compared with Example 1, only step 6 is changed, that is, trypsin is added to the polysaccharide aqueous solution in an amount of 150 U / mL, and the solution is subjected to a constant temperature treatment at 40° C. The remaining operations are the same as those in Example 1.

[0127] The polysaccharide extraction rate reached 23% and the purity reached 79%.

[0128] Comparative Example 5

[0129] Compared with Example 1, only the dialysis time in step 8 was changed to 55 h, and the remaining operations were the same as in Example 1.

[0130] The polysaccharide extraction rate reached 21% and the purity reached 77%.

[0131] Comparative Example 6

[0132] Prepared according to the method of Example 1 in Chinese patent CN 111196865 A.

[0133] The polysaccharide extraction rate reaches 30% and the purity reaches 82%.

[0134] Test Example 1

[0135] In vitro cytotoxicity experiment to screen the optimal concentration of Dendrobium officinale polysaccharide affecting HaCaT cell viability:

[0136] (1) Cell culture: Human immortalized keratinocytes HaCaT were cultured in DMEM complete medium containing 10% FBS and 1% double antibody at 37° C., 5% CO 2 , and 95% air.

[0137] (2) Cell treatment: HaCaT cells were adjusted to a state where cells in the logarithmic growth phase were selected. After treatment with 10 μg / mL 5-FU (dissolved in DMSO) for 24 h, the cells were replaced with a medium. Subsequently, the polysaccharides prepared in Example 1 (10 μg / mL, 50 μg / mL, 100 μg / mL, 500 μg / mL and 1000 μg / mL) were added according to a concentration gradient for 24 h. Subsequent tests were performed. The specific groups were as follows:

[0138] Experimental setup:

[0139] A.Control group

[0140] B.5-FU group

[0141] C. 5-FU + Dendrobium officinale polysaccharide (10 μg / mL) group

[0142] D. 5-FU + Dendrobium officinale polysaccharide (50 μg / mL) group

[0143] E. 5-FU + Dendrobium officinale polysaccharide (100 μg / mL) group

[0144] F. 5-FU + Dendrobium officinale polysaccharide (500 μg / mL) group

[0145] G.5-FU+Dendrobium officinale polysaccharide (1000 μg / mL) group

[0146] (3) MTT assay for cell viability in each group: After observation, discard the culture medium, add 20 μL MTT (5 mg / mL) to each well, culture in a cell culture incubator for 4 h, discard the supernatant, add 100 μL dimethyl sulfoxide to each well, oscillate in the dark for 30 min, measure the optical density (OD) at 570 nm, and calculate the cell proliferation rate.

[0147] (4) Cell proliferation rate (%) = OD value of the test group / OD value of the blank control group × 100%.

[0148] (5) Experimental results are as follows Figure 3 The results showed that the optimal concentration of Dendrobium officinale polysaccharide affecting HaCaT cell viability was 500 μg / mL, so this optimal concentration was selected for subsequent experiments.

[0149] Test Example 2

[0150] The cell-based mechanism of action of Dendrobium officinale polysaccharide in alleviating cellular oxidative stress response by upregulating Nrf2 signaling pathway and inhibiting endoplasmic reticulum stress (ERS) to alleviate 5-FU-induced cell damage and inflammatory response was verified.

[0151] (1) Cell treatment: Adjust the state of HaCaT cells, select cells in the logarithmic growth phase, and treat them with 10 μg / mL 5-FU for 24 h according to the experimental groups. Then, change the medium of the cells, and then add Dendrobium officinale polysaccharide to continue the treatment for 24 h. Then, perform subsequent tests. The specific groups are as follows:

[0152] Experimental setup:

[0153] A.Control group

[0154] B.5-FU group

[0155] C. 5-FU + crude polysaccharide of Dendrobium officinale in Example 1

[0156] D. 5-FU + Dendrobium officinale high molecular weight polysaccharide group prepared in Example 1

[0157] (2) The MTT method was used to detect the cell viability of each group.

[0158] (3) The ROS level in each group of cells was detected by a reactive oxygen species detection kit and photographed using a fluorescence microscope.

[0159] (4) The kit was used to detect the activity or level of SOD, GSH-Px and MDA in each group of cells.

[0160] (5) ELISA detection kit was used to detect the expression levels of IL-1β, TNF-α, IL-6, and IL-10 in the cell supernatant of each group.

[0161] (6) Real-time PCR was used to detect the expression of IL-1β, TNF-α, IL-6, and IL-10 mRNA in each group of cells.

[0162] (7) The cytoplasmic proteins and nuclear proteins of each group were separated and detected. Western blot was used to detect the expression of nuclear protein Nrf2, the expression of cytoplasmic proteins Nrf2 and Keap1, and the expression of total proteins CHOP (DDIT3), HO-1, and NQO1.

[0163] The experimental results are as follows Figure 4-6 The results showed that compared with Dendrobium officinale polysaccharide, Dendrobium officinale high-molecular polysaccharide can significantly increase nuclear Nrf2 expression, and has higher anti-inflammatory and antioxidant activities, and better improvement effect on 5-FU-induced inflammatory cells. The purified high-molecular polysaccharide improves the therapeutic effect, proving that the polysaccharide prepared by the present invention has more application value.

[0164] Test Example 3

[0165] Study on the related effects and mechanisms of Dendrobium officinale polysaccharide in improving mucosal damage in rats with oral mucositis (OM)

[0166] (1) Establishment of oral mucositis rat model

[0167] 42 male SD rats aged 6-8 weeks and weighing 180-220 g were randomly divided into 6 groups. 5-FU (60 mg / kg) was injected intraperitoneally every 5 days (days 0, 5, and 10), once each time, for a total of 3 times. On the 4th day, the rats were anesthetized and dragged in a straight line twice on the right cheek pouch with an 18-gauge needle to induce ulcerative oral mucositis in rats.

[0168] (2) Drug treatment

[0169] After the model was successfully established, the rats were given Dendrobium officinale polysaccharide, ERS inhibitor 4-PBA (100 mg / kg), and NF-κB inhibitor PDTC (100 mg / kg) solution by gavage once a day for 12 days. The day of gavage administration was regarded as the first day, and the rats were killed on the 12th day for subsequent testing. The specific groups are as follows:

[0170] Experimental setup:

[0171] A. Normal control group (no modeling, intragastric administration of normal saline)

[0172] B. Model group (modeling, intragastric administration of normal saline)

[0173] C. Dendrobium officinale crude polysaccharide (modeling, 100 mg / kg polysaccharide gavage)

[0174] D. Dendrobium officinale high molecular weight polysaccharide (modeling, 100 mg / kg polysaccharide gavage)

[0175] (3) After modeling, the rats in each group were weighed and their weight changes were recorded once a day;

[0176] (4) After modeling, the food intake and oral mucosal inflammation area of ​​each group of rats were observed and recorded every day;

[0177] (5) HE staining was used to observe the pathological changes of the ulcer site in the right buccal mucosal tissue of rats in each group, and oral mucositis was graded and scored;

[0178] Histopathological grading and scoring criteria: 0 points: no vascular dilation in the epithelium and conjunctiva, no or mild inflammatory cell infiltration, no hemorrhage, edema, ulcer or abscess; 1 point: mild vascular congestion, epithelial regeneration area, mild cell invasion and damage to monocytic leukocytes, no hemorrhage, edema, ulcer or abscess; 2 points: moderate vascular congestion, watery epithelial degeneration (vacuolation), moderate cell infiltration, polymorphonuclear leukocytes predominate, there are hemorrhage areas, edema, occasional small ulcers, and no abscesses; 3 points: obvious vascular congestion and vasodilation, polymorphonuclear cells predominate, there are hemorrhage areas, edema, abscesses and large areas of ulcers.

[0179] (6) Immunohistochemistry (IHC) was used to observe the expression of GRP78 BIP, CHOP (DDIT3), and NF-κBp65 in the right buccal mucosa tissue of rats in each group;

[0180] (7) Real-time PCR was used to detect the expression of IL-1β, TNF-α, IL-6, IL-10, GRP78 BIP, and CHOP (DDIT3) mRNA in the right buccal mucosa tissue of rats in each group;

[0181] (8) Western blot was used to detect the expression of total protein NF-κB p65, p-NF-κBp65 (Ser 536), GRP78 BIP, BAX, and BCL2 in the right buccal mucosal tissue of rats in each group;

[0182] (9) The kit was used to detect the activities or levels of SOD, CAT and MDA in the right buccal mucosal tissue of rats in each group.

[0183] Test Example 4

[0184] Study on the related effects and mechanisms of fast-soluble hyaluronic acid microneedle patches (HA MNs) loaded with Dendrobium officinale polysaccharides in improving mucosal damage in rats with oral mucositis (OM)

[0185] (1) Preparation of Dendrobium officinale polysaccharide microneedle patch

[0186] The rapidly soluble HA microneedle patches with crude polysaccharides of Dendrobium officinale and high molecular weight polysaccharides of Dendrobium officinale loaded on the needle tips were prepared by the fractional casting method.

[0187] (2) Biosafety evaluation of Dendrobium officinale polysaccharide microneedle patch

[0188] Human oral keratinocytes (HOK cells) were cultured in a 96-well plate, and after 24 hours, different concentrations (0, 1, 2.5 and 5 mg / mL) of crude polysaccharides from Dendrobium officinale and HA microneedle patch dissolution solutions from Dendrobium officinale were added. After 24 hours of culture, a culture medium containing 10% CCK-8 was added, incubated for 2 hours, and the absorbance was measured using an enzyme-linked detector. The specific groups are as follows:

[0189] A.Control group

[0190] B. Non-drug HA microneedle patch

[0191] C. Dendrobium officinale crude polysaccharide (1 mg / mL) group

[0192] D. Dendrobium officinale crude polysaccharide (2.5 mg / mL) group

[0193] E. Dendrobium officinale crude polysaccharide (5 mg / mL) group

[0194] F. Dendrobium officinale high molecular weight polysaccharide (1 mg / mL) group

[0195] G. Dendrobium officinale high molecular weight polysaccharide (2.5 mg / mL) group

[0196] H. Dendrobium officinale high molecular weight polysaccharide (5 mg / mL) group

[0197] (3) Establishment of oral mucositis rat model

[0198] 42 male SD rats aged 6-8 weeks and weighing 180-220 g were randomly divided into 6 groups. 5-FU (60 mg / kg) was injected intraperitoneally every 5 days (days 0, 5, and 10), once each time, for a total of 3 times. On the 4th day, the rats were anesthetized and dragged in a straight line twice on the right cheek pouch with an 18-gauge needle to induce ulcerative oral mucositis in rats.

[0199] (4) Drug treatment

[0200] After the model was successfully established, the rats were treated with crude polysaccharides of Dendrobium officinale and HA microneedle patches of Dendrobium officinale high molecular weight polysaccharides according to the groups, once a day for 12 days. The day of the start of drug administration was regarded as the first day, and the rats were killed on the 12th day for subsequent testing. The specific groups are as follows:

[0201] A. Normal control group (no modeling, no drug-containing microneedle patch)

[0202] B. Model group (modeling, without drug-free microneedle patch)

[0203] C. Dendrobium officinale polysaccharide (modeling, Dendrobium officinale polysaccharide HA microneedle patch)

[0204] D. Dendrobium officinale high molecular weight polysaccharide (modeling, Dendrobium officinale high molecular weight polysaccharide HA microneedle patch)

[0205] (5) Real-time PCR was used to detect the expression of IL-1β, TNF-α, IL-6, IL-10, GRP78 BIP, and CHOP (DDIT3) in the right buccal mucosal tissue of rats in each group.

[0206] (6) ELISA detection kit was used to detect the expression levels of IL-1β, TNF-α, IL-6, and IL-10 in the right buccal mucosal tissue of rats in each group.

[0207] (7) The kit was used to detect the activities or levels of SOD, CAT and MDA in the right buccal mucosal tissue of rats in each group.

[0208] The experimental results are as follows Figure 7-11 The results showed that compared with the polysaccharide of Dendrobium officinale, the rat mucosal epithelium in the high-molecular-weight polysaccharide group of Dendrobium officinale was closer to that in the normal control group. The cells basically returned to normal, the thickness of the cell layer was restored, and the infiltration of inflammatory cells was significantly reduced. The high-molecular-weight polysaccharide of Dendrobium officinale had a better inhibitory effect on the level of inflammatory factors, higher anti-inflammatory and antioxidant activities, and better improvement effect on oral mucositis. The purified high-molecular-weight polysaccharide improved the therapeutic effect, proving that the polysaccharide prepared by the present invention has more application value.

[0209] Finally, it should be noted that the above content is only used to illustrate the technical solution of the present invention, rather than to limit the scope of protection of the present invention. Simple modifications or equivalent substitutions of the technical solution of the present invention by ordinary technicians in this field do not deviate from the essence and scope of the technical solution of the present invention.

Claims

1. A method for preparing a Dendrobium officinale polysaccharide having the effect of improving oral mucositis, characterized in that: The following steps are involved: S1: Mix Dendrobium officinale with the solution at a weight ratio of 1:8-18, collect the residue after 6-12 hours; repeat the extraction 4-5 times, and combine the residue; S2: Mix the filter residue obtained in S1 with 15-35 times the volume of water, extract at 65-90°C for 1-4h, extract 2-3 times, and combine the filtrates; S3: The filtrate obtained in S2 is concentrated at 40-50°C and precipitated with alcohol to obtain a precipitate; S4: removing the solvent from the precipitate obtained in S3 to obtain crude polysaccharide of Dendrobium officinale; S5: Deproteinize by Sevage enzyme-linked method and collect the upper polysaccharide aqueous solution.

2. The preparation method according to claim 1, characterized in that: The solution described in S1 is an ethanol-water solution, and the volume fraction of ethanol is 70%-90%; the weight ratio described in S1 is 1:10-15.

3. The preparation method according to claim 1, characterized in that: The extraction temperature in S2 is 70-85°C, and the extraction time is 2-3h; S2 also includes the step of: centrifuging the obtained filtrate; the centrifugation parameters are: centrifugation at a speed of 7500-8500rpm / min for 10-25min.

4. The preparation method according to claim 1, characterized in that: The concentration temperature in S3 is 45°C; The alcohol precipitation solvent described in S3 is an ethanol aqueous solution, and the volume fraction of ethanol is 90%-95%; The alcohol precipitation described in S3 also includes standing and centrifuging; the standing temperature is 3-5°C and the time is 10-16h.

5. The preparation method according to claim 1, characterized in that: The specific operation of the Sevage enzyme-linked method for deproteinization described in S5 is: take crude polysaccharide of Dendrobium officinale and add solvent to form a solution with a mass fraction of 3-5%, add trypsin, treat at a constant temperature of 45-55°C, take the supernatant and mix it with Sevage reagent, so that the final concentration of Sevage reagent is 18-22%; the Sevage reagent is a mixed solution of chloroform and n-butanol; the volume ratio of chloroform and n-butanol is 3-4:

1.

6. The preparation method according to claim 1, characterized in that: The preparation method further comprises the steps of dialyzing the polysaccharide aqueous solution obtained in S5 for 40-50 hours, with a molecular retention capacity of 3300-3600 kDa, and concentrating to obtain a crude product.

7. The preparation method according to claim 6, characterized in that: The preparation method further comprises the steps of: The crude product is dissolved and separated by ultrafiltration using a 75-85 kDa membrane for 5-10 times, and the permeate is collected.

8. The preparation method according to claim 7, characterized in that: The ultrafiltration separation is as follows: under the conditions of a pressure of 0.15-0.25 MPa and a flow rate of 25-35 L / h, a 75-85 kDa membrane is used to continuously ultrafilter 5-10 times until the maximum permeate yield is reached, and the permeate is collected.

9. A Dendrobium officinale polysaccharide having the effect of improving oral mucositis, characterized in that: Prepared by the preparation method according to any one of claims 1 to 8.

10. Use of the Dendrobium officinale polysaccharide prepared by the preparation method according to any one of claims 1 to 8 in preparing a product for preventing, improving or treating oral mucositis.

Citation Information

Cited By

  • Drug-loaded integrated double-crosslinking dendrobium polysaccharide gel as well as preparation method and application thereof

    CN122557432A